Researchers studied over 8,000 adults to understand why people with COPD (a serious lung disease) often develop weak bones. They found that people with COPD are more than twice as likely to have osteoporosis, a condition where bones become fragile. Interestingly, men with COPD faced an even higher risk than women. The study suggests that certain COPD medications and sleep problems may partly explain this connection. These findings could help doctors better protect the bone health of their COPD patients, especially by monitoring medication use and sleep quality.
The Quick Take
- What they studied: Whether people with COPD (chronic obstructive pulmonary disease, a lung condition) are more likely to develop osteoporosis (weak bones), and whether this risk differs between men and women.
- Who participated: 8,274 adults aged 50 and older from a large U.S. health survey conducted between 2005 and 2018. Participants reported whether they had been diagnosed with COPD and osteoporosis, and researchers measured their bone density using a special X-ray scan.
- Key finding: People with COPD were 2.24 times more likely to have osteoporosis compared to those without COPD. Men with COPD faced an even higher risk (4.85 times more likely), while women with COPD had a moderately increased risk (1.86 times more likely).
- What it means for you: If you have COPD, especially if you’re male, you should talk to your doctor about bone health screening and monitoring. Two factors that may partly explain this connection—certain COPD medications and sleep problems—are things your doctor can help you manage.
The Research Details
This study used data from NHANES, a large national health survey that collects information from thousands of Americans. Researchers looked at survey responses from 2005 to 2018 and focused on adults aged 50 and older. They compared people who reported having COPD with those who didn’t, and checked whether they also had osteoporosis. To measure bone strength more objectively, they used bone density measurements from special X-ray scans (called DXA scans) that some participants had received. The researchers used statistical methods to account for other factors that might affect bone health, like age, smoking history, weight, and race.
This approach is important because it allowed researchers to study a very large, representative group of Americans rather than a small group in a laboratory. By looking at real-world data and using bone density measurements alongside self-reported diagnoses, they could confirm whether the connection between COPD and weak bones is real and significant. The study also examined whether this connection works differently for men versus women, which helps doctors provide better, personalized care.
This study has several strengths: it included a large number of participants (over 8,000), used actual bone density measurements to confirm diagnoses, and examined data from multiple years. However, because it’s based on survey data, people’s memories about their diagnoses might not be perfectly accurate. The study is observational, meaning researchers observed patterns but couldn’t prove that COPD directly causes weak bones—other unmeasured factors could play a role. The findings about how medications and sleep problems contribute to the connection are exploratory and would benefit from further research.
What the Results Show
The study found a clear connection between COPD and osteoporosis. Overall, people with COPD were 2.24 times more likely to have osteoporosis than people without COPD. This difference was statistically significant, meaning it’s very unlikely to have happened by chance. When researchers looked at bone density measurements from X-ray scans, they confirmed this pattern: people with COPD had lower bone density scores. The sex difference was striking: men with COPD had a much stronger association with osteoporosis (4.85 times higher risk) compared to women with COPD (1.86 times higher risk). This suggests that COPD may affect bone health differently in men and women, though researchers noted this difference was only marginally statistically significant.
The exploratory analysis identified two factors that may partially explain why COPD and weak bones are connected. First, prednisone (a common COPD medication that reduces inflammation) accounted for about 5% of the increased osteoporosis risk. Second, sleep problems accounted for about 9% of the increased risk. Together, these two factors explained roughly 14% of the connection. Interestingly, vitamin D levels did not appear to meaningfully explain the relationship, suggesting that vitamin D deficiency alone isn’t the main reason COPD patients develop weak bones.
Previous research has shown that COPD and osteoporosis often occur together, but this study is one of the largest to examine this connection in a representative U.S. population and to specifically look at sex differences. The finding that men with COPD face a higher relative risk of osteoporosis is somewhat surprising and adds new information to the field. The identification of prednisone use and sleep problems as partial explanations aligns with what scientists already suspected about how COPD affects bone health, but this study provides quantitative evidence for these connections.
Because this study relied on people’s self-reported diagnoses of COPD and osteoporosis, some cases may have been missed or misclassified. The study is observational, so it shows associations but cannot prove that COPD causes osteoporosis—other unmeasured factors could be responsible. The exploratory mediation analysis (examining how prednisone and sleep problems contribute) is preliminary and needs confirmation in future studies. The study couldn’t account for all possible factors affecting bone health, such as physical activity levels or calcium intake. Additionally, the findings may not apply equally to all racial and ethnic groups, though the study did examine some racial differences.
The Bottom Line
If you have COPD, discuss bone health screening with your doctor, particularly if you’re male or over age 50. Ask your doctor about your current medications, especially long-term use of prednisone or similar steroids, as these may affect bone strength. Work with your healthcare team to improve sleep quality if you have sleep problems, as this may help protect your bones. Consider asking about vitamin D and calcium intake, though the research suggests these alone don’t fully explain the COPD-osteoporosis connection. These recommendations are based on moderate evidence and should be personalized to your specific situation.
This research is most relevant for people with COPD, particularly men over age 50. It’s also important for doctors treating COPD patients to be aware of the increased bone health risks. Family members of people with COPD should understand this connection so they can support preventive care. People considering COPD risk factors (like smoking) should know that COPD carries additional health consequences beyond lung problems. This research is less directly applicable to people without COPD, though it reinforces the importance of bone health across all populations.
Bone health changes happen gradually over months and years. If you make changes based on these findings—such as improving sleep or adjusting medications—you likely won’t notice improvements in bone strength for several months. Bone density is typically measured every 1-2 years with DXA scans, so this is a reasonable timeframe for monitoring whether interventions are working. The benefits of addressing modifiable factors like sleep quality and medication management may accumulate over time.
Want to Apply This Research?
- Track sleep quality and duration daily (aim for 7-9 hours per night), and log any COPD medications taken, especially corticosteroids like prednisone. Note the dose and frequency. This creates a record to discuss with your doctor and helps identify patterns between sleep, medications, and how you’re feeling.
- Set a daily sleep schedule with consistent bedtime and wake time. If you take prednisone or similar medications, set reminders to take them as prescribed and discuss with your doctor whether the dose can be minimized. Use the app to log sleep disturbances and discuss patterns with your healthcare provider to address underlying sleep problems.
- Create a quarterly review where you assess trends in sleep quality and medication use. Schedule bone density screening appointments as recommended by your doctor (typically every 1-2 years). Use the app to prepare questions for your doctor visits about bone health, medication side effects, and sleep management strategies. Track any new symptoms or concerns related to bone pain or fractures.
This research summary is for educational purposes only and should not replace professional medical advice. If you have COPD or concerns about bone health, consult with your healthcare provider before making any changes to your treatment plan or lifestyle. This study shows associations between COPD and osteoporosis but does not prove direct causation. Individual risk factors vary, and personalized medical evaluation is essential for appropriate diagnosis and treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.